Hompland, Ivar, et al. “Discontinuation of Imatinib in Patients With Oligometastatic Gastrointestinal Stromal Tumour Who Are in Complete Radiological Remission: A Prospective Multicentre Phase II Study”. Acta Oncologica, vol. 63, no. 1, May 2024, pp. 288-93, doi:10.2340/1651-226X.2024.39851.